Harrington, J., Arps, K., Wu, A., Carnicelli, A. R., Chiswell, K., Chrischilles, E., … Patel, M. R. (2022). Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence. In EUROPEAN HEART JOURNAL (Vol. 43, pp. 2709–2709).

Harrington, J., K. Arps, A. Wu, A. R. Carnicelli, K. Chiswell, E. Chrischilles, G. Shantha, et al. “Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence.” In EUROPEAN HEART JOURNAL, 43:2709–2709, 2022.

Harrington J, Arps K, Wu A, Carnicelli AR, Chiswell K, Chrischilles E, et al. Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence. In: EUROPEAN HEART JOURNAL. 2022. p. 2709–2709.

Harrington, J., et al. “Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence.” EUROPEAN HEART JOURNAL, vol. 43, 2022, pp. 2709–2709.

Harrington J, Arps K, Wu A, Carnicelli AR, Chiswell K, Chrischilles E, Shantha G, Vanwormer J, Mundl H, Viethan T, Alexander JH, Lopes RD, Washam J, Patel MR. Reduced dose, but not reduced risk: rates of inappropriate apixaban dose reduction and stroke and bleeding incidence. EUROPEAN HEART JOURNAL. 2022. p. 2709–2709.